title: Fourth complete remission with immunosuppression withdrawal and irinotecan after both autologous and allogeneic transplants for diffuse large B cell lymphoma.
authors.forename: Neel K
authors.initials: NK
authors.lastname: Gupta
authors.forename: Juliet N
authors.initials: JN
authors.lastname: Barker
authors.forename: James W
authors.initials: JW
authors.lastname: Young
authors.forename: Ariela
authors.initials: A
authors.lastname: Noy
mesh_terms: D000328:Adult; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003131:Combined Modality Therapy; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000077146:Irinotecan; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy*; D012074:Remission Induction; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous; D016896:Treatment Outcome
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D007166:Immunosuppressive Agents; D000077146:Irinotecan; D016572:Cyclosporine; D002166:Camptothecin